Internal Medicine Residency News, April 15, 2019
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for April 15, 2019.
D'Silva teaches at VA Health Training Program
The VA Women's Musculoskeletal Health Training Program wrapped up last week at the National SimLEARN Center in Orlando, Florida
DOC's Fresh Produce Program
Nutrition is a vital part of public health, yet access to good quality food for low-income individuals can be problematic.
Faculty Spotlight: David Halpern, MD
Meet David Halpern, MD, a consulting associate in our division. Learn more about his work, family, and interests in our interview below.
GIM recent funding awards: Oct 2018 - March 2019
Congratulations to the 5 faculty members who were recipients of recent research funding
Jenny Van Kirk to take on new roles in residency program, undergraduate medical education
Jenny Van Kirk, MD, currently the chief medical resident for Duke University Hospital, will serve as the associate director of Undergraduate Medical Education (UME) for the Department of Medicine as well as assistant program director for the Internal Medicine Residency Program, effective July 1, 2019.
2 faculty from the Department of Medicine inducted into AAP
Two Department Medicine faculty members were inducted into the Association of American Physicians (AAP) during a joint April 6 meeting of the AAP, the Ame
Rheumatic Diseases and Pregnancy: How do Outcomes Correlate to Patient-Reported Measures?
When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?
Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.
Rheumatic Diseases and Pregnancy: Should HCQ Dose Change in Pregnancy?
For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry.